GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
发明人:
Sanjay KHANDEKAR,Patrick MAYES,Joanna OPALINSKA
申请号:
US16646836
公开号:
US20200270354A1
申请日:
2018.09.12
申请国别(地区):
US
年份:
2020
代理人:
摘要:
Disclosed herein is a method of treating cancer, such as multiple myeloma, involving the combination of an anti-BCMA antigen binding protein (e.g., an anti-BCMA antibody) and a proteasome inhibitor (e.g. bortezomib). The combinations can also include an anti-inflammatory compound (e.g. dexamethasone).